KR900017549A - 암의 혈청진단법 - Google Patents
암의 혈청진단법 Download PDFInfo
- Publication number
- KR900017549A KR900017549A KR1019890006447A KR890006447A KR900017549A KR 900017549 A KR900017549 A KR 900017549A KR 1019890006447 A KR1019890006447 A KR 1019890006447A KR 890006447 A KR890006447 A KR 890006447A KR 900017549 A KR900017549 A KR 900017549A
- Authority
- KR
- South Korea
- Prior art keywords
- carboxypeptidase
- serum
- diagnostic method
- human
- cancer serum
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/14—Devices for taking samples of blood ; Measuring characteristics of blood in vivo, e.g. gas concentration within the blood, pH-value of blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- General Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 본 발명의 혈청진단법에 의한 각종 혈청과 항원과의 반응성을 나타낸 도면임.
Claims (8)
- 사람의 모노클로날 항체에 의해 인식될 수 있고 사람외의 다른 동물로부터 유래되는 항원을 사용하는 것을 포함하는 암의 혈청진단법.
- 제1항에 있어서, 사람의 모노클로날 항체가 사람-사람 하이브리도마HB4C5에 의해 생성되는 것인 혈청진단법.
- 제1항 또는 제2항에 있어서, 항원이 카르복시펩티다제인 혈청진단법.
- 제3항에 있어서, 카르복시펩티다제가 카르복시펩티다제 A인 혈청 진단법.
- 제3항에 있어서, 카르복시펩티다제가 카르복시펩티다제 B인 혈청 진단법.
- 제1항 내지 제5항 중 어느 하나에 있어서, 동물이 돼지, 소 또는 마우스인 혈청진단법.
- 제1항 내지 제6항 중 어느 하나에 있어서, 항원과 반응할 수 있는 혈액내 항체의 양이 결정된 혈청진단법.
- 제1항 내지 제7항 중 어느 하나에 있어서, 효소 면역 분석법이 사용된 혈청진단법.※ 참고사항 : 최초출원내용에 의하여 공개하는 것임.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11628988 | 1988-05-13 | ||
| JP1-9254 | 1989-01-18 | ||
| JP1009254A JP2675117B2 (ja) | 1988-05-13 | 1989-01-18 | がんの血清測定法 |
| JP63-116289 | 1989-05-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR900017549A true KR900017549A (ko) | 1990-12-19 |
Family
ID=26343938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019890006447A KR900017549A (ko) | 1988-05-13 | 1989-05-13 | 암의 혈청진단법 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US5094942A (ko) |
| JP (1) | JP2675117B2 (ko) |
| KR (1) | KR900017549A (ko) |
| DE (1) | DE3915344A1 (ko) |
| FR (1) | FR2631450B1 (ko) |
| GB (1) | GB2218807B (ko) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2659449A1 (ko) * | 1990-03-08 | 1991-09-13 | Morinaga & Co | |
| US5484704A (en) * | 1992-11-12 | 1996-01-16 | Baylor College Of Medicine | Monoclonal antibody for diagnostic use in ovarian cancer |
| WO1995004827A1 (en) * | 1993-08-10 | 1995-02-16 | Biotech Australia Pty. Ltd. | Tick antigen |
| US5993815A (en) * | 1996-11-08 | 1999-11-30 | University Of Vermont | Methods and compositions for inhibiting the activation of thrombin-activatable fibrinolysis inhibitor (TAFI) |
| JP2001095584A (ja) * | 1999-09-30 | 2001-04-10 | Kouji Egawa | 癌細胞特異的ｈｌａ−ｆ抗原、およびそれを用いた癌の診断方法 |
| US20060073526A1 (en) * | 2004-10-05 | 2006-04-06 | Wako Pure Chemical Industries, Ltd | Antibodies, assay method by using them and judgment method for pancreas cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1174800B (it) * | 1983-11-21 | 1987-07-01 | Alberto Bartorelli | Metodo per la determinazione di immunoglobuline umane specifiche per gli antigeni dei carcinomi umani e sua utilizzazione nella sierodiognosi di forme primitive tumorali |
-
1989
- 1989-01-18 JP JP1009254A patent/JP2675117B2/ja not_active Expired - Lifetime
- 1989-05-05 US US07/347,638 patent/US5094942A/en not_active Expired - Fee Related
- 1989-05-10 DE DE3915344A patent/DE3915344A1/de not_active Withdrawn
- 1989-05-11 FR FR898906203A patent/FR2631450B1/fr not_active Expired - Lifetime
- 1989-05-12 GB GB8910969A patent/GB2218807B/en not_active Expired - Lifetime
- 1989-05-13 KR KR1019890006447A patent/KR900017549A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US5094942A (en) | 1992-03-10 |
| DE3915344A1 (de) | 1989-11-23 |
| FR2631450A1 (fr) | 1989-11-17 |
| JPH0249162A (ja) | 1990-02-19 |
| FR2631450B1 (fr) | 1991-11-15 |
| GB2218807A (en) | 1989-11-22 |
| GB8910969D0 (en) | 1989-06-28 |
| GB2218807B (en) | 1992-05-20 |
| JP2675117B2 (ja) | 1997-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0483194T3 (da) | IgG3-antistoffer med forkortet hængselsregion og en komplementaktiveringstest | |
| ES556865A0 (es) | Un metodo de inmunoensayo. | |
| LV10538A (lv) | Imunologiski saistamas vielas noteiksanas panemiens biologiska skidruma un diagnostikas lidzeklis | |
| KR890701632A (ko) | 사람 인터루킨-4에 대한 모노클로날 항체 및 이를 생성하는 하이브리도마 | |
| ES445768A1 (es) | Metodo de preparacion de un reactivo en fase solida para usoen el radio inmunoensayo de antigenos y anticuerpos y de realizacon del radio inmunoensayo. | |
| ES512498A0 (es) | "metodo y su correspondiente aparato para el ensayo de anticuerpos con respecto a antigenos solubles". | |
| DE3883073D1 (de) | Einschritt-immuntest zur bestimmung von antigen-spezifischen antikoerpern aus einer der immunglobulin-klassen a, m, d oder e und dazu geeignetes mittel. | |
| ES2070488T5 (es) | Procedimiento para la diagnosis de enfermedades tumorales. | |
| EP0291086A2 (de) | Verfahren zur Bestimmung eines Antikörpers in menschlichen Körperflüssigkeiten | |
| ES2033823T3 (es) | Ensayo en cuanto a cancer de mama humano. | |
| KR900017549A (ko) | 암의 혈청진단법 | |
| DK0457804T3 (da) | M-CSF-monoklonale antistoffer, som genkender en neutraliserende, konformational epitop | |
| ATE61735T1 (de) | Fuer endotoxine spezifische antikoerper. | |
| ATE230418T1 (de) | Monoklonaler antikörper gegen das humane mx- protein mxa | |
| KR920017670A (ko) | 모노클로날 항체 | |
| SE7907118L (sv) | Bestemning av human beta?712-mikroglobulin | |
| ATE77243T1 (de) | E87ag-antigen des pseudomonas aeruginosa, monoklonale antikoerper dagegen und hybridom. | |
| KR890008313A (ko) | 안티 pci모노클론 항체 | |
| McCarthy et al. | Interference in immunoenzymometric assays caused by IgM anti-mouse IgG antibodies | |
| AR246766A1 (es) | Hibridoma apropiado para producir anticuerpos monoclonales utiles para el diagnostico de brucelosis. | |
| SE9602234D0 (sv) | A novel diagnostic method utilizing ECP, and reagents to be used in the methods | |
| PT81050B (pt) | Anticorpo monoclonal anti-urocinase e processo para a preparacao de composicoes de materia de teste biologicos que o utilizam | |
| ES2169153T3 (es) | Anticuerpos opsonicos ampliamente reactivos que reaccionan con antigenos estafilococicos comunes. | |
| FR2376864A1 (fr) | Reactif et procede de determination du cholecalciferol | |
| KR900018678A (ko) | 엘라스타제-1의 면역 분석법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19890513 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19940203 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19890513 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19970320 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 19970528 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 19970320 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |